Skip to main content
SpringerLink
Log in

Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism

  • Workshop On Screening And Economics
  • Published:
Journal of Inherited Metabolic Disease

Summary

A comparison between the cost of identification and care of patients with phenylketonuria (PKU) and congenital hypothyroidism (CH) and the expenditure for the care of untreated retarded patients has been established on the basis of the activity of the Nord-Pas-de-Calais regional screening centre and of interviews with patients' families. The analysis yields a benefit-cost ratio of 6.6 for PKU and 13.8 for CH prophylaxis. However, cost-benefit varies depending on the economic partner, i.e. the patient's family, Social Security or Administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Dagenais, D. L., Courville, L. and Dagenais, M. G. A cost-benefit analysis of the Quebec network of genetic medicine.Soc. Sci. Med. 20 (1985) 601–607

    Google Scholar 

  • Dhondt, J. L. and Farriaux, J. P. Integration of neonatal screening procedure. The French experience. In Naruse, H. and Irie, M. (eds.)Neonatal Screening, Excerpta Medica, Amsterdam, 1983, pp. 438–443

    Google Scholar 

  • Dhondt, J. L., Farriaux, J. P., Raux, M., Paux, E., Bouchery, A. M. and Debersée, J. Bilan du dépistage de la phénylcétonurie et de l'hypothyroïdie par le centre de Lille.Arch. Fr. Pediatr. 44 (1987) 787–790

    Google Scholar 

  • Dhondt, J. L., Farriaux, J. P., Lebrun, T., Sailly, J. C. Etude coût/bénéfice du dépistage néonatal de la phénylcétonurie et de l'hypothyroïdie.Pédiatrie 43 (1988) 345–348

    Google Scholar 

  • Frézal, J., Farriaux, J. P., Briard, M. L., Dhondt, J. L., Boschetti, R. and Travert, G. The French program of systematic neonatal screening. In Knoppers, B. M. and Laberge, C. (eds.)Genetic Screening, From Newborns to DNA Typing, Elsevier, Amsterdam, 1990, pp. 41–64

    Google Scholar 

  • Hormuth, R. P. Update of the 1984 Chicago meeting on quality assurance in screening. In Knoppers, B. M. and Laberge, C. (eds.)Genetic Screening. From Newborns to DNA Typing, Elsevier, Amsterdam, 1990, pp. 3–10

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculté de Médecine, Centre Régional de Dépistage des Maladies Métaboliques de l'Enfant, place de Verdun, 59000, Lille, France

    J. -L. Dhondt & J. -P. Farriaux

  2. CRESGE, rue François Baës, 59046, Lille Cedex, France

    J. -C. Sailly & T. Lebrun

Authors
  1. J. -L. Dhondt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. -P. Farriaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. -C. Sailly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Lebrun
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dhondt, J.L., Farriaux, J.P., Sailly, J.C. et al. Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism. J Inherit Metab Dis 14, 633–639 (1991). https://doi.org/10.1007/BF01797933

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01797933

Keywords

Search

Navigation